您好, 歡迎來到化工儀器網(wǎng)！ 登錄| 免費注冊| 產(chǎn)品展廳| 收藏商鋪|
您好, 歡迎來到化工儀器網(wǎng)！ 登錄| 免費注冊| 產(chǎn)品展廳| 收藏商鋪|
13829799985
當前位置：BPS Bioscience Inc.>>CAR T-Cell Therapy Cell Lines>> 78771NY-ESO-1 TCR (c259) CD8+ NFAT-Luciferase Reporter Jurkat Cell Line
| 參 考 價 | 面議 |
產(chǎn)品型號78771
品 牌BPS Bioscience
廠商性質(zhì)生產(chǎn)商
所 在 地
更新時間：2024-11-26 16:00:34瀏覽次數(shù)：218次
聯(lián)系我時，請告知來自 化工儀器網(wǎng)
Anti-BCMA CAR /NFAT (Luciferase) Re
Anti-CD19 CAR / NFAT (Luciferase) R
This cell line was generated from the T Cell Receptor (TCR) Knockout NFAT Luciferase Reporter Jurkat Cell Line (BPS Bioscience #78556) by overexpression of human CD8 (NM_001768.6) and NY-ESO-1 TCR (c259) using lentiviral transduction (CD8a Lentivirus #78648 and NY-ESO-1 -Specific TCR Lentivirus Clone c259 #78676). The human TCR clone c259 that specifically recognizes antigen NY-ESO-1 (New York esophageal squamous cell carcinoma 1).
Figure 1: Illustration of the functional co-culture assay used to validate the NY-ESO-1 TCR (c259) CD8+ NFAT-Luciferase Reporter Jurkat cell line.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供，信息內(nèi)容的真實性、準確性和合法性由相關企業(yè)負責，化工儀器網(wǎng)對此不承擔任何保證責任。
溫馨提示：為規(guī)避購買風險，建議您在購買產(chǎn)品前務必確認供應商資質(zhì)及產(chǎn)品質(zhì)量。
化工儀器網(wǎng)